New drug aims to protect kidneys in IgA nephropathy patients
NCT ID NCT03762850
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial tests sparsentan, a new drug, against irbesartan (a standard treatment) in 406 adults with IgA nephropathy, a kidney disease. The goal is to see if sparsentan better protects kidney function over about 2 years. Participants must have significant protein in their urine and stable kidney function at the start.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sparsentan
- What this could lead to
- If successful, sparsentan could offer a new treatment option to slow kidney function decline in people with IgA nephropathy.
- What could go wrong
- This is a Phase 3 trial, but results are not yet final. The drug may not prove significantly better than existing treatments, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOGLOBULIN A NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Travere Investigational Site
Birmingham, Alabama, 35233, United States
-
Travere Investigational Site
Homewood, Alabama, 35209, United States
-
Travere Investigational Site
Glendale, California, 91206, United States
-
Travere Investigational Site
Montebello, California, 90640, United States
-
Travere Investigational Site
Northridge, California, 91324, United States
-
Travere Investigational Site
San Diego, California, 92103-6204, United States
-
Travere Investigational Site
San Diego, California, 92103, United States
-
Travere Investigational Site
Stanford, California, 94205, United States
-
Travere Investigational Site
Denver, Colorado, 80230, United States
-
Travere Investigational Site
Coral Springs, Florida, 33071, United States
-
Travere Investigational Site
Hollywood, Florida, 33021, United States
-
Travere Investigational Site
Miami, Florida, 33136, United States
-
Travere Investigational Site
Miami, Florida, 33186, United States
-
Travere Investigational Site
Winter Park, Florida, 32789, United States
-
Travere Investigational Site
Lawrenceville, Georgia, 30046, United States
-
Travere Investigational Site
Nampa, Idaho, 83687, United States
-
Travere Investigational Site
Hinsdale, Illinois, 60521, United States
-
Travere Investigational Site
Muncie, Indiana, 47303, United States
-
Travere Investigational Site
Kansas City, Kansas, 66160, United States
-
Travere Investigational Site
Louisville, Kentucky, 40202, United States
-
Travere Investigational Site
Boston, Massachusetts, 02215, United States
-
Travere Investigational Site
Springfield, Massachusetts, 01104, United States
-
Travere Investigational Site
Worcester, Massachusetts, 01608, United States
-
Travere Investigational Site
Minneapolis, Minnesota, 55404, United States
-
Travere Investigational Site
Reno, Nevada, 89511, United States
-
Travere Investigational Site
Fresh Meadows, New York, 11365, United States
-
Travere Investigational Site
New York, New York, 10032, United States
-
Travere Investigational Site
Cleveland, Ohio, 44106, United States
-
Travere Investigational Site
Columbus, Ohio, 43210, United States
-
Travere Investigational Site
Philadelphia, Pennsylvania, 19104, United States
-
Travere Investigational Site
Columbia, South Carolina, 29203, United States
-
Travere Investigational Site
El Paso, Texas, 79935, United States
-
Travere Investigational Site
Fort Worth, Texas, 76104, United States
-
Travere Investigational Site
Houston, Texas, 77054, United States
-
Travere Investigational Site
Lewisville, Texas, 75057, United States
-
Travere Investigational Site
San Antonio, Texas, 78207, United States
-
Travere Investigational Site
Salt Lake City, Utah, 84115, United States
-
Travere Investigational Site
Salt Lake City, Utah, 84132, United States
-
Travere Investigational Site
Tacoma, Washington, 98405, United States
-
Travere Investigational Site
Marshfield, Wisconsin, 54449, United States
-
Travere Investigational Site
Concord, New South Wales, 2139, Australia
-
Travere Investigational Site
Gosford, New South Wales, 2250, Australia
-
Travere Investigational Site
Kingswood, New South Wales, 2747, Australia
-
Travere Investigational Site
New Lambton Heights, New South Wales, 2305, Australia
-
Travere Investigational Site
Randwick, New South Wales, 2031, Australia
-
Travere Investigational Site
St Leonards, New South Wales, 2065, Australia
-
Travere Investigational Site
Birtinya, Queensland, 4575, Australia
-
Travere Investigational Site
Adelaide, South Australia, 5000, Australia
-
Travere Investigational Site
Reservoir, Victoria, 3073, Australia
-
Travere Investigational Site
Nedlands, Western Australia, 6009, Australia
-
Travere Investigational Site
Bonheiden, 2820, Belgium
-
Travere Investigational Site
Bruges, 8310, Belgium
-
Travere Investigational Site
Ghent, 9000, Belgium
-
Travere Investigational Site
Kortrijk, 8500, Belgium
-
Travere Investigational Site
Liège, 4000, Belgium
-
Travere Investigational Site
Roeselare, 8800, Belgium
-
Travere Investigational Site
Osijek, 31000, Croatia
-
Travere Investigational Site
Zagreb, 10000, Croatia
-
Travere Investigational Site
Prague, 10034, Czechia
-
Travere Investigational Site
Prague, 12808, Czechia
-
Travere Investigational Site
Tallinn, 10617, Estonia
-
Travere Investigational Site
Tallinn, 13419, Estonia
-
Travere Investigational Site
Tartu, 50406, Estonia
-
Travere Investigational Site
Marseille, Bouches-du-Rhone, 13005, France
-
Travere Investigational Site
Montpellier, Herault, 34295, France
-
Travere Investigational Site
Grenoble, Isere, 38043, France
-
Travere Investigational Site
Paris, Paris, 75015, France
-
Travere Investigational Site
Saint-Priest-en-Jarez, Pays de la Loire Region, 42270, France
-
Travere Investigational Site
Clermont-Ferrand, Puy De Dome, 63003, France
-
Travere Investigational Site
Créteil, 94010, France
-
Travere Investigational Site
Paris, 75475, France
-
Travere Investigational Site
Villingen-Schwenningen, Baden-Wurttemberg, 78052, Germany
-
Travere Investigational Site
Hanover, Lower Saxony, 30625, Germany
-
Travere Investigational Site
Aachen, North Rhine-Westphalia, 52074, Germany
-
Travere Investigational Site
Düsseldorf, North Rhine-Westphalia, 40210, Germany
-
Travere Investigational Site
Kaiserslautern, Rheinland Palatinate, 67655, Germany
-
Travere Investigational Site
Trier, Rheinland Palatinate, 54292, Germany
-
Travere Investigational Site
Kiel, Schleswig-Holstein, 23538, Germany
-
Travere Investigational Site
Kiel, Schleswig-Holstein, 24105, Germany
-
Travere Investigational Site
Jena, Thuringia, 07747, Germany
-
Travere Investigational Site
Berlin, 10117, Germany
-
Travere Investigational Site
Kwun Tong, Kowloon, Hong Kong
-
Travere Investigational Site
Lai Chi Kok, Kowloon, Hong Kong
-
Travere Investigational Site
Shatin, New Territories, Hong Kong
-
Travere Investigational Site
Tsuen Wan, New Territories, Hong Kong
-
Travere Investigational Site
Hong Kong, Hong Kong
-
Travere Investigational Site
Ranica, Bergamo, 24020, Italy
-
Travere Investigational Site
Milan, Lombardy, 20162, Italy
-
Travere Investigational Site
Bari, 70124, Italy
-
Travere Investigational Site
Catania, 95123, Italy
-
Travere Investigational Site
Catanzaro, 88100, Italy
-
Travere Investigational Site
Lecco, 23900, Italy
-
Travere Investigational Site
Modena, 41124, Italy
-
Travere Investigational Site
Pavia, 27100, Italy
-
Travere Investigational Site
Roma, 00168, Italy
-
Travere Investigational Site
Torino, 10126, Italy
-
Travere Investigational Site
Kaunas, LT-50009, Lithuania
-
Travere Investigational Site
Vilnius, LT-08661, Lithuania
-
Travere Investigational Site
Grafton, Auckland, 1142, New Zealand
-
Travere Investigational Site
Hamilton, 3200, New Zealand
-
Travere Investigational Site
Hastings, 4120, New Zealand
-
Travere Investigational Site
New Plymouth, 4310, New Zealand
-
Travere Investigational Site
Krakow, 31-559, Poland
-
Travere Investigational Site
Lodz, 93-347, Poland
-
Travere Investigational Site
Olsztyn, 10-124, Poland
-
Travere Investigational Site
Olsztyn, 10-561, Poland
-
Travere Investigational Site
Warsaw, 04-749, Poland
-
Travere Investigational Site
Wroclaw, 50-566, Poland
-
Travere Investigational Site
Coimbra, 3000-075, Portugal
-
Travere Investigational Site
Lisbon, 1069-166, Portugal
-
Travere Investigational Site
Lisbon, 1649-035, Portugal
-
Travere Investigational Site
Loures, 2674-514, Portugal
-
Travere Investigational Site
Setúbal, 2910-446, Portugal
-
Travere Investigational Site
Vila Nova de Gaia, 4434-502, Portugal
-
Travere Investigational Site
Seongnam-si, Gyeonggi-do, 13620, South Korea
-
Travere Investigational Site
Anyang-si, 14068, South Korea
-
Travere Investigational Site
Busan, 47392, South Korea
-
Travere Investigational Site
Incheon, 21565, South Korea
-
Travere Investigational Site
Seoul, 02841, South Korea
-
Travere Investigational Site
Seoul, 03080, South Korea
-
Travere Investigational Site
Seoul, 06273, South Korea
-
Travere Investigational Site
Seoul, 110-746, South Korea
-
Travere Investigational Site
Seoul, 120-752, South Korea
-
Travere Investigational Site
Seoul, 135-710, South Korea
-
Travere Investigational Site
Palma de Mallorca, Balearic Islands, 07120, Spain
-
Travere Investigational Site
Sagunto, Valencia, 46520, Spain
-
Travere Investigational Site
Barcelona, 08003, Spain
-
Travere Investigational Site
Barcelona, 08025, Spain
-
Travere Investigational Site
Barcelona, 08035, Spain
-
Travere Investigational Site
Barcelona, 08036, Spain
-
Travere Investigational Site
Madrid, 28007, Spain
-
Travere Investigational Site
Madrid, 28040, Spain
-
Travere Investigational Site
Madrid, 28041, Spain
-
Travere Investigational Site
Seville, 41009, Spain
-
Travere Investigational Site
Valencia, 46014, Spain
-
Travere Investigational Site
Valencia, 46017, Spain
-
Travere Investigational Site
Zaragoza, 50009, Spain
-
Travere Investigational Site
Hualien City, 970, Taiwan
-
Travere Investigational Site
Kaohsiung City, 807, Taiwan
-
Travere Investigational Site
Kaohsiung City, 81362, Taiwan
-
Travere Investigational Site
New Taipei City, 220, Taiwan
-
Travere Investigational Site
Taichung, 40705, Taiwan
-
Travere Investigational Site
Reading, Berkshire, RG1 5AN, United Kingdom
-
Travere Investigational Site
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
-
Travere Investigational Site
Middlesbrough, Cleveland, TS4 3BW, United Kingdom
-
Travere Investigational Site
Derby, Derbyshire, DE22 3DT, United Kingdom
-
Travere Investigational Site
Brighton, East Sussex, BN2 5BE, United Kingdom
-
Travere Investigational Site
London, Greater London, E1 4AT, United Kingdom
-
Travere Investigational Site
London, Greater London, SE1 9RT, United Kingdom
-
Travere Investigational Site
Manchester, Greater Manchester, M13 9WL, United Kingdom
-
Travere Investigational Site
Salford, Greater Manchester, M6 8HD, United Kingdom
-
Travere Investigational Site
Preston, Lancashire, PR2 9HT, United Kingdom
-
Travere Investigational Site
Leicester, Leicestershire, LE5 4PW, United Kingdom
-
Travere Investigational Site
Edinburgh, Scotland, EH16 4SA, United Kingdom
-
Travere Investigational Site
Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom
-
Travere Investigational Site
Glasgow, Strathclyde, G11 6NT, United Kingdom
-
Travere Investigational Site
Carshalton, Surrey, SM5 1AA, United Kingdom
-
Travere Investigational Site
Cardiff, West Glamorgan, CF14 4XW, United Kingdom
-
Travere Investigational Site
Birmingham, West Midlands, B9 5SS, United Kingdom
-
Travere Investigational Site
Liverpool, L9 7AL, United Kingdom
-
Travere Investigational Site
London, E1 1FR, United Kingdom
-
Travere Investigational Site
London, SE5 9RS, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug aims to slow kidney failure in common kidney disease
- New drug aims to plug kidney leaks in multiple diseases
- New drug shows promise for kidney disease patients
- New antibody VIS649 tested in humans for first time to fight kidney disease
- New drug shows promise for slowing kidney disease in IgA nephropathy patients
- New drug shows promise for kidney disease in phase 2 trial